How much funding has GenePath Diagnostics raised?

GenePath Diagnostics has raised $333K in total funding, most recently a Seed round.

Who are GenePath Diagnostics's investors?

GenePath Diagnostics's investors include Saama Capital, Snow Leopard Ventures.

When was GenePath Diagnostics founded?

GenePath Diagnostics was founded in 2008.

Where is GenePath Diagnostics headquartered?

GenePath Diagnostics is headquartered in Pune, India.

What industry is GenePath Diagnostics in?

GenePath Diagnostics operates in Biotech, Healthcare.

How many employees does GenePath Diagnostics have?

GenePath Diagnostics has 51-200 employees.

GenePath Diagnostics

Pune, India · Founded 2008 · $333K raised

Biotech

Healthcare

Headquarters: Pune
Employees: 51–200
Founded: 2008
Business Model: B2B

Website: genepathdx.com
Total Funding: $333K
Last Round: $333K SeedNov 2020
Rounds: 2

About

GenePath Diagnostics is a next-generation molecular diagnostics company founded in 2008 and headquartered in Pune, India, with US operations in Ann Arbor, Michigan. The company develops and manufactures in vitro molecular diagnostics products and custom reagents spanning infectious diseases, oncology, hematology, pharmacogenetics, and inherited genetic disorders, serving clinical labs in India and distributing products globally across Europe, Africa, the Middle East, and Southeast Asia. GenePath operates NABL-accredited clinical laboratories in Pune and an R&D and production lab in Ann Arbor, with over 100 laboratories worldwide using its test kits or custom reagents.

Summary

GenePath Diagnostics is a Biotech company based in Pune, India, founded in 2008. It has raised $333K in total across 2 rounds, most recently a $333K Seed round in Nov 2020. Investors include Saama Capital and Snow Leopard Ventures.